BABA
Alibaba Group Holding Limited
BABA has slightly lower modeled downside risk, despite its lower overall score.
CLAR
Clarus Corporation
CLAR has the edge over BABA overall, supported by stronger fundamentals.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
CLAR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Stable |
CLAR's revenue and balance sheet are currently stable, but its profitability and cash flow are under pressure.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
CLAR PE Valuation
CLAR has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 33x next year's earnings.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over CLAR on the outlook, with more favorable revenue expectations.
CLAR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CLAR to return to profit, with revenue holding steady. However, they disagree widely on these estimates.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over CLAR on earnings quality, reporting a profit while its opponent remains loss making.
CLAR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.16 | — |
| Q3 2026 | -$0.69 | +$1.43 |
| Q2 2026 | -$0.82 | +$1.34 |
| Q1 2026 | -$1.16 | +$0.92 |
| Q4 2025 | -$1.21 | +$0.16 |
| Q3 2025 | -$2.12 | -1731% |
| Q2 2025 | -$2.16 | -1300% |
| Q1 2025 | -$2.08 | -900% |
| Q4 2024 | -$1.37 | -$1.10 |
CLAR is still losing money, but far less than before: $0.69 per share over the past year, against $2.22 at its worst in late 2023.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over CLAR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over CLAR on profitability, with a higher operating margin.
CLAR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $71.2M | +2.7% |
| Q2 2026 | $56.2M | +1.6% |
| Q1 2026 | $61.9M | +2.5% |
| Q4 2025 | $65.4M | -8.4% |
| Q3 2025 | $69.3M | +3.3% |
| Q2 2025 | $55.2M | -2.2% |
| Q1 2025 | $60.4M | -13% |
| Q4 2024 | $71.4M | +1377% |
CLAR's revenue fell from its 2021 peak and has held roughly level since: $71M last quarter, up 2.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.7% | +9 points |
| Q2 2026 | 8.1% | +28 points |
| Q1 2026 | -9.8% | +1.4 points |
| Q4 2025 | -60% | +11 points |
| Q3 2025 | -4.4% | +3.6 points |
| Q2 2025 | -20% | -5.3 points |
| Q1 2025 | -11% | -1.4 points |
| Q4 2024 | -70% | +496 points |
CLAR's operating margin was 4.7% last quarter, up 9 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
CLAR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.4M | -$443K |
| Q2 2026 | $636K | +$11.9M |
| Q1 2026 | -$5.7M | -$2.4M |
| Q4 2025 | $11.6M | -19% |
| Q3 2025 | -$7M | +$2.4M |
| Q2 2025 | -$11.3M | -$10.6M |
| Q1 2025 | -$3.3M | +$15M |
| Q4 2024 | $14.4M | +8.2% |
CLAR has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
CLAR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -74K shares |
| 1 year | -0.3% | -107K shares |
| 3 years | +2.2% | +825K shares |
| 5 years | +5.9% | +2.1M shares |
| Available history | +23% | +7.2M shares |
CLAR has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $447,000 |
| Q1 2026 | $32,000 |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $42,000 |
| Q4 2024 | — |
CLAR spent $479,000 buying back its own shares over the past year, more than ten times what it spent the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
CLAR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | 2.9x | Moderate |
| Q2 2022 | 2.9x | Moderate |
| Q1 2022 | 3.2x | Elevated |
| Q4 2021 | 3.3x | Elevated |
| Q3 2021 | 5.8x | High |
| Q2 2021 | 0.7x | Very low |
| Q1 2021 | 1.2x | Healthy |
| Q4 2020 | 1.3x | Healthy |
CLAR's net debt is about 2.9 years of its operating earnings (EBITDA), down from 5.8 years a year ago.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
CLAR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 80.0 | Overbought |
| Stochastic | 89.2 | Overbought |
CLAR's weekly RSI is 80 (overbought) and its Stochastic is 89 (overbought).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
CLAR PE vs Consumer Cyclical Sector
| Metric | CLAR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CLAR has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
CLAR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.07 | 27% above |
| 20 week MA | $3.74 | 38% above |
| 50 week MA | $3.38 | 53% above |
| 100 week MA | $3.58 | 44% above |
| 200 week MA | $5.20 | 0.6% below |
CLAR has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
CLAR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.6 | $15.4 | +13% |
| 2021 | $15.4 | $26.7 | +73% |
| 2022 | $26.7 | $7.15 | -73% |
| 2023 | $7.15 | $6.90 | -3.5% |
| 2024 | $6.90 | $4.54 | -34% |
| 2025 | $4.54 | $3.38 | -26% |
| 2026 YTD | $3.38 | $5.17 | +53% |
CLAR has the edge over BABA on returns for 2026, with the stronger performance.